National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting, 23093 [2023-07893]
Download as PDF
<![CDATA[
23093
Federal Register / Vol. 88, No. 72 / Friday, April 14, 2023 / Notices
ACTION:
Notice.
Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection: Federalwide
Assurance (FWA) Form.
Type of Collection: Extension.
SUPPLEMENTARY INFORMATION:
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be
received on or before June 13, 2023.
ADDRESSES: Submit your comments to
Sherrette.Funn@hhs.gov or by calling
(202) 795–7714.
FOR FURTHER INFORMATION CONTACT:
When submitting comments or
requesting information, please include
the document identifier 0990–0278–60D
and project title for reference, to
Sherrette A. Funn, email:
Sherrette.Funn@hhs.gov, or call (202)
795–7714 the Reports Clearance Officer.
SUMMARY:
OMB No. 0990–0278
Abstract: The Office of the Assistant
Secretary for Health, Office for Human
Research Protections (OHRP), is
requesting a three-year extension of the
OMB No. 0990–0278, Federalwide
Assurance (FWA) Form, with no
changes in the collected information.
The purpose of the FWA form is to
provide a simplified procedure for
institutions engaged in research
conducted or supported by the
Department of Health and Human
Services (HHS) to satisfy the assurance
requirements of (1) Section 491(a) of the
Public Health Service Act (the PHS Act)
(42 U.S.C. 289); and (2) HHS regulations
for the protection of human subjects at
45 CFR 46.103.
Likely Respondents: Institutions
engaged in HHS-conducted or—
supported research involving human
subjects.
ANNUALIZED BURDEN HOUR TABLE
Number of
respondents
Form name
Hours per
response
Response
burden hours
Federalwide Assurance (FWA) ........................................................................
14,000
2.0
30/60
14,000
Total ..........................................................................................................
........................
........................
........................
14,000
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
[FR Doc. 2023–07908 Filed 4–13–23; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
ddrumheller on DSK120RN23PROD with NOTICES1
Number of responses per
respondent
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting of the Board of
Scientific Counselors, National Institute
of Neurological Disorders and Stroke.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute of Neurological
Disorders and Stroke, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
VerDate Sep<11>2014
17:45 Apr 13, 2023
Jkt 259001
constitute a clearly unwarranted
invasion of personal privacy.
INTERNATIONAL TRADE
COMMISSION
Name of Committee: Board of Scientific
Counselors, National Institute of
Neurological Disorders and Stroke.
Date: May 7–9, 2023.
Time: May 7, 2023, 2:00 p.m. to 7:30 p.m.;
May 8, 2023, 8:30 a.m. to 9:00 p.m.; May 9,
2023, 9:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: The Bethesdan Hotel, 8120
Wisconsin Avenue, Bethesda, Maryland
20814.
Contact Person: Jeffrey S. Diamond, Ph.D.,
Acting Scientific Director, c/o Caren Collins,
National Institute of Neurological Disorders
and Stroke, NIH, Building 35, Room GF–149,
Bethesda, MD 20892, 301–435–1896,
diamondj@ninds.nih.gov; collinsca@
ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
[Investigation No. 337–TA–1290]
Dated: April 10, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–07893 Filed 4–13–23; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00098
Fmt 4703
Sfmt 4703
Certain Refrigerator Water Filtration
Devices and Components Thereof;
Notice of Commission Final
Determination To Issue a Limited
Exclusion Order and Cease and Desist
Orders; Termination of the
Investigation
U.S. International Trade
Commission.
ACTION: Notice.
AGENCY:
Notice is hereby given that
the U.S. International Trade
Commission has determined to issue a
limited exclusion order (‘‘LEO’’) barring
entry of certain infringing refrigerator
water filtration devices and components
thereof that are imported by or on behalf
of: Freshlab LLC of Gainesville, Florida;
Isave Strategic Marketing Group LLC
d/b/a Isave of New York, New York; GT
Sourcing Inc. d/b/a GT Sourcing of
Monsey, New York; Refresh Filters LLC
d/b/a Refresh My Water of New York,
New York; All Filters LLC d/b/a
Allfilters of Salt Lake City, Utah; Jiangsu
Angkua Environmental Technical Co.,
Ltd. of Nantong, China (‘‘Jiangsu’’);
Shenzen Hangling E-Commerce Co. Ltd
d/b/a Best Belvita of Elmhurst, Illinois;
SUMMARY:
E:\FR\FM\14APN1.SGM
14APN1
]]>Agencies
[Federal Register Volume 88, Number 72 (Friday, April 14, 2023)]
[Notices]
[Page 23093]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-07893]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting of the Board
of Scientific Counselors, National Institute of Neurological Disorders
and Stroke.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Institute of Neurological Disorders and Stroke, including consideration
of personnel qualifications and performance, and the competence of
individual investigators, the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors, National
Institute of Neurological Disorders and Stroke.
Date: May 7-9, 2023.
Time: May 7, 2023, 2:00 p.m. to 7:30 p.m.; May 8, 2023, 8:30
a.m. to 9:00 p.m.; May 9, 2023, 9:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate personnel qualifications and
performance, and competence of individual investigators.
Place: The Bethesdan Hotel, 8120 Wisconsin Avenue, Bethesda,
Maryland 20814.
Contact Person: Jeffrey S. Diamond, Ph.D., Acting Scientific
Director, c/o Caren Collins, National Institute of Neurological
Disorders and Stroke, NIH, Building 35, Room GF-149, Bethesda, MD
20892, 301-435-1896, [email protected];
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: April 10, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-07893 Filed 4-13-23; 8:45 am]
BILLING CODE 4140-01-P
